Marcus Dalton

Vice President Patents at CureVac AG - Boston, MA, US

Marcus Dalton's Colleagues at CureVac AG
Igor Splawski

Chief Scientific Officer

Contact Igor Splawski

Sandra Lazzaro

Senior Scientist Clinical Immunomonitoring

Contact Sandra Lazzaro

Julia Walz

Group Manager GMP Service Provider

Contact Julia Walz

Barbara Philippe

SVP Manufacturing and Supply Chain, Managing Director

Contact Barbara Philippe

Martin Falk

Executive Medical Director, Oncology

Contact Martin Falk

Paula Muresan

Scientist, Product Design and Formulation

Contact Paula Muresan

View All Marcus Dalton's Colleagues
Marcus Dalton's Contact Details
HQ
617-377-4040
Location
London,England,United Kingdom
Company
CureVac AG
Marcus Dalton's Company Details
CureVac AG logo, CureVac AG contact details

CureVac AG

Boston, MA, US • 250 - 499 Employees
BioTech/Drugs

CureVac is a biopharmaceutical company that develops and commercializes mRNA-based therapies for the treatment of cancer and infectious diseases.

mRNA therapeutics cancer therapies prophylactic vaccines molecular therapies
Details about CureVac AG
Frequently Asked Questions about Marcus Dalton
Marcus Dalton currently works for CureVac.
Marcus Dalton's role at CureVac is Vice President Patents.
Marcus Dalton's email address is ***@curevac.com. To view Marcus Dalton's full email address, please signup to ConnectPlex.
Marcus Dalton works in the Research industry.
Marcus Dalton's colleagues at CureVac AG are Igor Splawski, Sandra Lazzaro, Julia Walz, Thomas Pruss, Barbara Philippe, Martin Falk, Paula Muresan and others.
Marcus Dalton's phone number is 617-377-4040
See more information about Marcus Dalton